CHR. HANSEN A/S: Financial statements 2020
CVR: 12516479
Source: annual report 2020, Danish Business Authority
01/09/2019 – 31/08/2020
CHR. HANSEN A/S (CVR 12516479) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 5,351,199,000 and a net result of DKK 1,153,070,000 compared with DKK 1,462,142,000 the year before. That is an increase of 2.5% compared with the year before. The profit margin was 21.5%. Equity in the 2020 report amounted to DKK 6,583,771,000. The solvency ratio was 52.2%.
- Revenue
- DKK 5,351,199,000
- Gross Profit
- DKK 3,332,977,000
- Profit/Loss
- DKK 1,153,070,000
- Equity
- DKK 6,583,771,000
- Total Assets
- DKK 12,622,141,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 5.4B | 3.3B | 1.2B | 6.6B | - |
| 2019 | 5.2B | 3.3B | 1.5B | 3.8B | - |
| 2018 | 5.3B | 2.9B | 1.3B | 3.3B | - |
| 2017 | 5.5B | 2.8B | 1.3B | 3B | - |
| 2016 | 4.8B | 2.4B | 1.1B | 2.6B | - |
Official annual report
How creditworthy is CHR. HANSEN A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of October 30, 2020, Lise Skaarup Mortensen has joined the board of directors of CHR. HANSEN A/S.
As of October 30, 2020, Søren Westh Lonning has left the board of directors of CHR. HANSEN A/S.
About CHR. HANSEN A/S
CHR. HANSEN A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 1988. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named CHR. HANSEN'S LABORATORIUM DANMARK A/S and A/S PSE NR. 2770. The management consists of Morten Enggaard Rasmussen. The board consists of Rainer Chapour Lehmann (chair), Anders Lund, Helle Rexen and Lisbet Kragelund. The company is owned by NOVOZYMES A/S. The company has 1,747 employees (2026). In 2025, the company reported revenue of DKK 6,820,616,000 and a net result of DKK 2,105,477,000 compared with DKK 1,891,419,000 the year before. Equity in the 2025 report amounted to DKK 11,263,718,000.